IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Windlas Biotech IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 401.54 Cr. The company is based in Dehradun and caters to Pharmaceutical sector. Dam Capital Advisors (Formerly Idfc Securities ) , IIFL Securities , SBI Capital Markets are the merchant bankers of Windlas Biotech IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 13th May 2021.
Windlas Biotech IPO open date is 4th August 2021 and close date is 6th August 2021. IPO Allotment Date is 11th August 2021 and Listing date is 16th August 2021.
IPO
Size:
₹ 401.54 Cr.
Avg IPO Size (Sector Based)
: ₹
1,342.04 cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Dam Capital
IPO by BRLM so far:
53
City:
Dehradun
IPO so far:
1
Revenue (annualised):
₹
430.70
cr. 
PE
Ratio:
64.00x
Average Sector PE Ratio: 25.12x
Windlas Biotech IPO size is ₹ 401.54 Cr. with IPO price of ₹ 460.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Dam Capital Advisors Limited (Formerly Idfc Securities Limited) is the book-running lead manager of the Windlas Biotech IPO. Link Intime India Private Limited is the Registrar for Windlas Biotech IPO.
Windlas Biotech IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Windlas Biotech IPO, based in Dehradun, operates in the Pharmaceutical sector with a focus on domestic pharmaceutical formulations contract development and manufacturing. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Windlas Biotech IPO size is ₹ 401.54 Cr. with fresh issue size of ₹ 401.54 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Windlas Biotech IPO is expected to be 11th August 2021, after the finalization of basis of allotment. Investors can check Windlas Biotech IPO allotment status on the registrars website, Link Intime India Private Limited . Windlas Biotech IPO refund dates are 12th August 2021.
Windlas Biotech IPO is expected to be listed on 16th August 2021.
The upper price band for the Windlas Biotech IPO is set at ₹ 460.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Windlas Biotech IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Windlas Biotech IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 6th August 2021. After submission, funds are blocked until the basis of allotment of Windlas Biotech IPO is finalised.
The merchant banker for Windlas Biotech IPO is Dam Capital Advisors Limited (Formerly Idfc Securities Limited) , IIFL Securities Limited , SBI Capital Markets Limited . Dam Capital Advisors Limited (Formerly Idfc Securities Limited) , IIFL Securities Limited , SBI Capital Markets Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Windlas Biotech IPO RHP for further details.
The registrar for Windlas Biotech IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Windlas Biotech IPO through their official website or helpline.
Windlas Biotech IPO was subscribed 22.44 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 401.54 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,342.04 Cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Dam Capital
IPO by BRLM so far:
53
City:
Dehradun
IPO so far:
1
Revenue (annualised):
₹ 427.60 cr.
PE
Ratio:
64.00x
Average Sector PE Ratio: 25.12x
Windlas Biotech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Windlas Biotech Financial Review Page
Merchant Banker(s) of Windlas Biotech IPO: Dam Capital Advisors Limited (Formerly Idfc Securities Limited) , IIFL Securities Limited , SBI Capital Markets Limited
Windlas Biotech IPO subscription was 22.44 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Windlas Biotech IPO listed at a listing price of 406.70 against the offer price of 460.00.
The current market price of Windlas Biotech is 901.25.
Why Us?
